// App-Quantinova.ai

: Real world data examining the use of Ixazomib, Lenalidomide and Dexamethasone (ILD) and Lenalidomide and Dexamethasone (LD) chemotherapy in Multiple Myeloma

Researchers

Presenter

  • Zara Sayar

Principal Investigators

  • Keonwoo Yi

  • Simon Cheesman

  • Selina Chavda

  • Lydia Lee

  • Charalampia Kyriakou

  • Xenofon Papanikolaou

  • Sajitha Sachchithanantham

  • Sahmeem Mahmood

  • Atul Mehta

  • Rakesh Popat

  • Ashutosh Wechalekar

  • Kwee Yong

  • Neil Rabin

Medical Centers

  • Department of Medical Oncology, University College London Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • Ixazomib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved